Biomarker testing patterns and patient outcomes for metastatic NSCLC, CRC, and metastatic/recurrent HNSCC at Texas Oncology.
2026 ASCO Annual Meeting
Front-line treatment approaches in multiple myeloma: real-world data from a community-based oncology network
Front. Oncol., 21 April 2026
Sec. Hematologic Malignancies
Management of CML in community setting: Basis for a quality initiative
2025 ASCO Quality Care Symposium
Real-world Outcomes Among Patients (Pts) with Relapsed or Refractory Multiple Myeloma (RRMM) Initiating Teclistamab (Tec) at a Large Community Oncology Center in the US
2025 International Myeloma Society Annual Meeting – Toronto, Canada | Virtual
Real-world treatment patterns and outcomes with trifluridine/tipiracil monotherapy or in combination with bevacizumab in metastatic colorectal cancer.
ASCO Annual Meeting, 2025
Biomarker testing patterns among patients newly diagnosed with prostate cancer in a community oncology network
ASCO Genitourinary Cancers Symposium 2025, Prostate Biomarkers Poster Session